These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 38765527
1. Early and late-onset preeclampsia: effects of DDAH2 polymorphisms on ADMA levels and association with DDAH2 haplotypes. Mendes FS, Luizon MR, Lopes ACDS, Pereira DA, Evangelista FCG, Godoi LC, Dusse LM, Alpoim PN. Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765527 [Abstract] [Full Text] [Related]
2. Polymorphisms in the promoter region of the dimethylarginine dimethylaminohydrolase 2 gene are associated with prevalence of hypertension. Maas R, Erdmann J, Lüneburg N, Stritzke J, Schwedhelm E, Meisinger C, Peters A, Weil J, Schunkert H, Böger RH, Lieb W. Pharmacol Res; 2009 Dec; 60(6):488-93. PubMed ID: 19666123 [Abstract] [Full Text] [Related]
3. Evidence for a protective role for the rs805305 single nucleotide polymorphism of dimethylarginine dimethylaminohydrolase 2 (DDAH2) in septic shock through the regulation of DDAH activity. Lambden S, Tomlinson J, Piper S, Gordon AC, Leiper J. Crit Care; 2018 Dec 11; 22(1):336. PubMed ID: 30538005 [Abstract] [Full Text] [Related]
4. Pilot study of the association of the DDAH2 -449G polymorphism with asymmetric dimethylarginine and hemodynamic shock in pediatric sepsis. Weiss SL, Yu M, Jennings L, Haymond S, Zhang G, Wainwright MS. PLoS One; 2012 Dec 11; 7(3):e33355. PubMed ID: 22428028 [Abstract] [Full Text] [Related]
5. Sequence variation in DDAH1 and DDAH2 genes is strongly and additively associated with serum ADMA concentrations in individuals with type 2 diabetes. Abhary S, Burdon KP, Kuot A, Javadiyan S, Whiting MJ, Kasmeridis N, Petrovsky N, Craig JE. PLoS One; 2010 Mar 01; 5(3):e9462. PubMed ID: 20209122 [Abstract] [Full Text] [Related]
6. DDAH1 and DDAH2 polymorphisms associate with asymmetrical dimethylarginine plasma levels in erectile dysfunction patients but not in healthy controls. Brites-Anselmi G, Azevedo AMM, Miyazaki AHL, Pinheiro LC, Coeli-Lacchini FB, de Andrade MF, Molina CAF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R. Nitric Oxide; 2019 Nov 01; 92():11-17. PubMed ID: 31394201 [Abstract] [Full Text] [Related]
7. Chronic renal impairment and DDAH2-1151 A/C polymorphism determine ADMA levels in type 2 diabetic subjects. Marra M, Marchegiani F, Ceriello A, Sirolla C, Boemi M, Franceschi C, Spazzafumo L, Testa I, Bonfigli AR, Cucchi M, Testa R. Nephrol Dial Transplant; 2013 Apr 01; 28(4):964-71. PubMed ID: 23129820 [Abstract] [Full Text] [Related]
8. Association of the -449GC and -1151AC polymorphisms in the DDAH2 gene with asymmetric dimethylarginine and erythropoietin resistance in Chinese patients on maintenance hemodialysis. Wang T, Zhang Y, Niu K, Wang L, Shi Y, Liu B. Clin Exp Pharmacol Physiol; 2017 Sep 01; 44(9):961-964. PubMed ID: 28590543 [Abstract] [Full Text] [Related]
9. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation. Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T. Vasc Med; 2013 Aug 01; 18(4):192-9. PubMed ID: 23892448 [Abstract] [Full Text] [Related]
10. Glu298Asp polymorphism of the endothelial nitric oxide synthase gene and plasma concentrations of asymmetric dimethylarginine in Turkish pre-eclamptic women without fetal growth retardation. Turan F, Ilhan N, Kaman D, Ateş K, Kafkasli A. J Obstet Gynaecol Res; 2010 Jun 01; 36(3):495-501. PubMed ID: 20598027 [Abstract] [Full Text] [Related]
11. Effects of eNOS polymorphisms on nitric oxide formation in healthy pregnancy and in pre-eclampsia. Sandrim VC, Palei AC, Sertorio JT, Cavalli RC, Duarte G, Tanus-Santos JE. Mol Hum Reprod; 2010 Jul 01; 16(7):506-10. PubMed ID: 20457799 [Abstract] [Full Text] [Related]
12. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity. Garbin U, Pasini AF, Stranieri C, Manfro S, Boccioletti V, Cominacini L. Pharmacol Res; 2007 Dec 01; 56(6):515-21. PubMed ID: 17977009 [Abstract] [Full Text] [Related]
13. Altered Bioavailability of Nitric Oxide and L-Arginine Is a Key Determinant of Endothelial Dysfunction in Preeclampsia. Tashie W, Fondjo LA, Owiredu WKBA, Ephraim RKD, Asare L, Adu-Gyamfi EA, Seidu L. Biomed Res Int; 2020 Dec 01; 2020():3251956. PubMed ID: 33145345 [Abstract] [Full Text] [Related]
14. Hypoxia causes increased monocyte nitric oxide synthesis which is mediated by changes in dimethylarginine dimethylaminohydrolase 2 expression in animal and human models of normobaric hypoxia. Lambden S, Martin D, Vanezis K, Lee B, Tomlinson J, Piper S, Boruc O, Mythen M, Leiper J. Nitric Oxide; 2016 Aug 31; 58():59-66. PubMed ID: 27319282 [Abstract] [Full Text] [Related]
16. Association of the DDAH2 gene polymorphism with type 2 diabetes and hypertension. Seo HA, Kim SW, Jeon EJ, Jeong JY, Moon SS, Lee WK, Kim JG, Lee IK, Park KG. Diabetes Res Clin Pract; 2012 Oct 01; 98(1):125-31. PubMed ID: 22579530 [Abstract] [Full Text] [Related]
17. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene. Zhang JG, Liu JX, Li ZH, Wang LZ, Jiang YD, Wang SR. Chin Med J (Engl); 2007 Dec 05; 120(23):2132-7. PubMed ID: 18167189 [Abstract] [Full Text] [Related]
18. Severely decreased activity of placental dimethylarginine dimethylaminohydrolase in pre-eclampsia. Anderssohn M, Maass LM, Diemert A, Lüneburg N, Atzler D, Hecher K, Böger RH. Eur J Obstet Gynecol Reprod Biol; 2012 Apr 05; 161(2):152-6. PubMed ID: 22285683 [Abstract] [Full Text] [Related]
19. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Kim YJ, Park BH, Park H, Jung SC, Pang MG, Ryu HM, Lee KS, Eom SM, Park HY. Twin Res Hum Genet; 2008 Feb 05; 11(1):77-83. PubMed ID: 18251679 [Abstract] [Full Text] [Related]
20. Protection of DDAH2 overexpression against homocysteine-induced impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells. Liu LH, Guo Z, Feng M, Wu ZZ, He ZM, Xiong Y. Cell Physiol Biochem; 2012 Feb 05; 30(6):1413-22. PubMed ID: 23171931 [Abstract] [Full Text] [Related] Page: [Next] [New Search]